bioAffinity Technologies News Update
bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW) shares recent Company news.
- bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW) shares recent Company news.
- Physicians outside of Texas are also signing up with our wholly owned subsidiary, Precision Pathology Laboratory Services, to order CyPath® Lung for their patients.
- bioAffinity Technologies’ National Sales Director Dallas Coleman announced that Jackie Kennedy has joined the Company as Pulmonary Sales Executive for CyPath® Lung in the San Antonio/Austin market.
- “Patients have told us how much they appreciate having a Patient Coach who can walk them through the collection process,” bioAffinity Technologies President and CEO Maria Zannes said.